Total Payments
$414,185
2024 Payments
$157,078
Companies
36
Transactions
757
Medicare Patients
8,452
Medicare Billing
$791,980
Payment Breakdown by Category
Other$355,075 (85.7%)
Travel$27,037 (6.5%)
Education$15,127 (3.7%)
Food & Beverage$13,691 (3.3%)
Consulting$3,255 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $355,075 | 180 | 85.7% |
| Travel and Lodging | $27,037 | 93 | 6.5% |
| Education | $15,127 | 10 | 3.7% |
| Food and Beverage | $13,691 | 473 | 3.3% |
| Consulting Fee | $3,255 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $390,521 | 400 | $0 (2024) |
| Intuitive Surgical, Inc. | $18,730 | 35 | $0 (2023) |
| Veran Medical Technologies, Inc. | $1,057 | 9 | $0 (2020) |
| GlaxoSmithKline, LLC. | $741.65 | 98 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $663.79 | 65 | $0 (2019) |
| JAZZ PHARMACEUTICALS INC. | $386.27 | 29 | $0 (2024) |
| GENZYME CORPORATION | $369.72 | 8 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $363.14 | 36 | $0 (2022) |
| Grifols USA, LLC | $154.18 | 8 | $0 (2024) |
| Genentech USA, Inc. | $128.78 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $157,078 | 171 | AstraZeneca Pharmaceuticals LP ($156,501) |
| 2023 | $157,848 | 157 | AstraZeneca Pharmaceuticals LP ($144,829) |
| 2022 | $51,098 | 71 | AstraZeneca Pharmaceuticals LP ($47,602) |
| 2021 | $27,111 | 51 | AstraZeneca Pharmaceuticals LP ($24,247) |
| 2020 | $1,573 | 10 | AstraZeneca Pharmaceuticals LP ($1,432) |
| 2019 | $4,355 | 75 | AstraZeneca Pharmaceuticals LP ($2,756) |
| 2018 | $10,535 | 112 | AstraZeneca Pharmaceuticals LP ($9,413) |
| 2017 | $4,586 | 110 | AstraZeneca Pharmaceuticals LP ($3,741) |
All Payment Transactions
757 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $150.00 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $89.39 | General |
| Category: Immunology | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Pulmonology | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $84.03 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Travel and Lodging | In-kind items and services | $309.54 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Travel and Lodging | In-kind items and services | $192.27 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $66.08 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $30.47 | General |
| Category: Respiratory | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $29.82 | General |
| Category: Narcoplepsy | ||||||
| 10/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $245.22 | General |
| Category: Respiratory | ||||||
| 10/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $91.93 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: NEUROLOGY | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,350.00 | General |
| Category: Respiratory | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Respiratory | ||||||
| 09/30/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $87.31 | General |
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: Immunology | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Respiratory | ||||||
| 09/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,156 | 3,231 | $342,190 | $192,259 |
| 2022 | 30 | 2,180 | 3,190 | $615,598 | $202,855 |
| 2021 | 22 | 2,114 | 2,802 | $265,971 | $190,148 |
| 2020 | 26 | 2,002 | 2,830 | $287,241 | $206,719 |
Total Patients
8,452
Total Services
12,053
Medicare Billing
$791,980
Procedure Codes
124
All Medicare Procedures & Services
124 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 184 | 403 | $45,570 | $30,841 | 67.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 62 | 190 | $46,780 | $29,580 | 63.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 85 | 639 | $51,120 | $28,491 | 55.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 177 | 220 | $32,085 | $18,620 | 58.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 90 | 93 | $18,524 | $11,910 | 64.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 62 | 62 | $16,653 | $8,132 | 48.8% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 118 | 133 | $17,913 | $7,878 | 44.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 168 | 177 | $12,298 | $6,663 | 54.2% |
| 31653 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | Facility | 2023 | 33 | 33 | $8,886 | $5,820 | 65.5% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 129 | 129 | $8,669 | $4,549 | 52.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 81 | $8,803 | $4,410 | 50.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 35 | $7,224 | $4,199 | 58.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 149 | 179 | $7,102 | $4,030 | 56.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 48 | 64 | $4,462 | $3,365 | 75.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 128 | 129 | $8,062 | $3,117 | 38.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 24 | 38 | $5,269 | $2,571 | 48.8% |
| G0408 | Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth | Office | 2023 | 17 | 29 | $6,717 | $2,239 | 33.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $3,757 | $2,199 | 58.5% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 36 | 36 | $5,882 | $1,994 | 33.9% |
| G0427 | Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth | Facility | 2023 | 13 | 13 | $5,451 | $1,677 | 30.8% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Office | 2023 | 17 | 17 | $3,611 | $1,409 | 39.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 77 | 85 | $3,275 | $1,385 | 42.3% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2023 | 20 | 20 | $2,133 | $1,382 | 64.8% |
| 98976 | Device supply with scheduled recording and transmission for remote monitoring of respiratory system, per 30 days | Office | 2023 | 38 | 38 | $3,420 | $1,358 | 39.7% |
| 77012 | Review by radiologist of ct guidance for needle placement | Facility | 2023 | 28 | 28 | $2,067 | $1,236 | 59.8% |
About Dr. Ryan Martin, MD
Dr. Ryan Martin, MD is a Internal Medicine healthcare provider based in Lincoln, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1790981082.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Martin, MD has received a total of $414,185 in payments from pharmaceutical and medical device companies, with $157,078 received in 2024. These payments were reported across 757 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($355,075).
As a Medicare-enrolled provider, Martin has provided services to 8,452 Medicare beneficiaries, totaling 12,053 services with total Medicare billing of $791,980. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Lincoln, NE
- Active Since 06/22/2007
- Last Updated 03/25/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1790981082
Products in Payments
- BREZTRI (Drug) $244,403
- AIRSUPRA (Drug) $100,888
- FASENRA (Biological) $24,147
- Da Vinci Surgical System (Device) $15,730
- BEVESPI AEROSPHERE (Drug) $10,470
- SYMBICORT (Drug) $4,699
- ION (Device) $3,000
- BREZTRI AEROSPHERE (Drug) $1,400
- Spin (Device) $1,057
- DALIRESP (Drug) $650.00
- DUPIXENT (Biological) $494.47
- LONHALA MAGNAIR (Drug) $254.62
- ANORO (Drug) $207.86
- Xyrem (Drug) $186.89
- Utibron (Drug) $186.51
- TRELEGY ELLIPTA (Drug) $183.14
- TAGRISSO (Drug) $168.40
- NUCALA (Biological) $168.17
- OFEV (Drug) $168.11
- Prolastin-C Liquid (Biological) $154.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lincoln
Brock Cookman, D.o, D.O
Internal Medicine — Payments: $694,509
Internal Medicine $694,509
Matthew Johnson, M.d, M.D
Internal Medicine — Payments: $307,471
Internal Medicine $307,471
Dr. Sherri Thomas, Do, DO
Internal Medicine — Payments: $100,336
Internal Medicine $100,336
Frank D'alessandro, Md Inc, MD INC
Internal Medicine — Payments: $86,860
Internal Medicine $86,860
Peter Gallagher, M.d, M.D
Internal Medicine — Payments: $83,162
Internal Medicine $83,162
Dr. Jeffrey Wayne, Md, MD
Internal Medicine — Payments: $81,162
Internal Medicine $81,162